The aim of this study was to assess monomer conversion, dimensional stability (mass and volume changes), biaxial flexural strength (BFS), and fluoride release of recently developed resin composites containing alkaline fillers (Cention N; CN) compared with resinmodified glass ionomer cements (RMGICs: Riva LC; RL and Fuji II LC; FL), and conventional composite (Z350). FL showed highest monomer conversion (88±2%) followed by RL (73±10%), CN (59±2%), and Z350 (50±2%). RL exhibited highest mass and volume increase (10.22±0.04 wt% and 19.4±0.2 vol%). CN exhibited higher BFS (180±20 MPa) than RMGICs but lower than Z350 (248±27 MPa). The highest cumulative fluoride release at 6 weeks was observed with RL (136±22 ppm) followed by CN (36±4 ppm) and FL (30±3 ppm). CN exhibited monomer conversion higher than the composite. CN also released fluoride in the range of that observed with RMGICs but with higher flexural strength.

The aim of this study was to prepare experimental resin-modified glass ionomer cements (RMGICs) containing low levels of hydroxyethyl methacrylate (HEMA) for pulp protection. Liquid and powder phases of the experimental RMGICs were polyacid functionalized with methacrylate groups and spherical pre-reacted glass fillers (SPG). Two types of liquid phase containing 0 wt. % HEMA (CM liquid) or 5 wt. % HEMA (CMH liquid) were formulated. The experimental RMGICs were prepared by mixing SPG fillers with CM liquid (F1) or CMH liquid (F2). Rheological properties were examined using a strain-controlled rheometer (n = 5). The Vickers microhardness (n = 5) and dentin shear bond strength (SBS) (n = 10) of the materials were tested. Commercial pulp protection materials (Vitrebond and TheraCal LC) were used as comparisons. The viscosity and surface microhardness of F1 (22 m Pa·s, 18 VHN) and F2 (18 m Pa·s, 16 VHN) were significantly higher than those of Vitrebond (6 mPa·s, 6 VHN) and TheraCal (0.1 mPa·s, 7 VHN). The SBS of F1 (10.7 MPa) and F2 (11.9 MPa) was comparable to that of Vitrebond (15.4 MPa) but higher than that of TheraCal LC (5.6 MPa). The addition of 5 wt. % HEMA showed no significant effect on viscosity, surface microhardness, or SBS of the experimental RMGICs. The experimental materials showed higher viscosity and microhardness but similar SBS when compared with the commercial RMGIC.

The aim of this study was to assess the effect of different commercial liquid phases (Ketac, Riva, and Fuji IX) and the use of spherical pre-reacted glass (SPG) fillers on cement maturation, fluoride release, compressive (CS) and biaxial flexural strength (BFS) of experimental glass ionomer cements (GICs). The experimental GICs (Ketac_M, Riva_M, FujiIX_M) were prepared by mixing SPG fillers with commercial liquid phases using the powder to liquid mass ratio of 2.5:1. FTIR-ATR was used to assess the maturation of GICs. Diffusion coefficient of fluoride (DF) and cumulative fluoride release (CF) in deionized water was determined using the fluoride ion specific electrode (n=3). CS and BFS at 24 h were also tested (n=6). Commercial GICs were used as comparisons. Riva and Riva_M exhibited rapid polyacrylate salt formation. The highest DF and CF were observed with Riva_M (1.65x10-9 cm2/s) and Riva (77 ppm) respectively. Using SPG fillers enhanced DF of GICs on average from ~2.5x10-9 cm2/s to ~3.0x10-9 cm2/s but reduced CF of the materials on average from ~51 ppm to ~42 ppm. The CS and BFS of Ketac_M (144 and 22 MPa) and Fuji IX_M (123 and 30 MPa) were comparable to commercial materials. Using SPG with Riva significantly reduced CS and BFS from 123 MPa to 55 MPa and 42 MPa to 28 MPa respectively. The use of SPG fillers enhanced DF but reduced CF of GICs. Using SPG with Ketac or Fuji IX liquids provided comparable strength to the commercial materials.

This study prepared composites for core build-up containing Sr/F bioactive glass nanoparticles (Sr/F-BGNPs) and monocalcium phosphate monohydrate (MCPM) to prevent dental caries. The effect of the additives on the physical/mechanical properties of the materials was examined. Dual-cured resin composites were prepared using dimethacrylate monomers with added Sr/F-BGNPs (5 or 10 wt%) and MCPM (3 or 6 wt%). The additives reduced the light-activated monomer conversion by ~10%, but their effect on the conversion upon self-curing was negligible. The conversions of light-curing or self-curing polymerization of the experimental materials were greater than that of the commercial material. The additives reduced biaxial flexural strength (191 to 155 MPa), modulus (4.4 to 3.3), and surface microhardness (53 to 45 VHN). These values were comparable to that of the commercial material or within the acceptable range of the standard. The changes in the experimental composites’ mass and volume (~1%) were similar to that of the commercial comparison. The color change of the commercial material (1.0) was lower than that of the experimental composites (1.5–5.8). The addition of Sr/F-BGNPs and MCPM negatively affected the physical/mechanical properties of the composites, but the results were satisfactory except for color stability.

This study prepared low-toxicity, elemental-releasing resin-modified glass ionomer cements (RMGICs). The effect of 2-hydroxyethyl methacrylate (HEMA, 0 or 5 wt%) and Sr/F-bioactive glass nanoparticles (Sr/F-BGNPs, 5 or 10 wt%) on chemical/mechanical properties and cytotoxicity were examined. Commercial RMGIC (Vitrebond, VB) and calcium silicate cement (Theracal LC, TC) were used as comparisons. Adding HEMA and increasing Sr/F-BGNPs concentration decreased monomer conversion and enhanced elemental release but without significant effect on cytotoxicity. Rising Sr/F-BGNPs reduced the strength of the materials. The degree of monomer conversion of VB (96%) was much higher than that of the experimental RMGICs (21–51%) and TC (28%). The highest biaxial flexural strength of experimental materials (31 MPa) was significantly lower than VB (46 MPa) (p < 0.01) but higher than TC (24 MPa). The RMGICs with 5 wt% HEMA showed higher cumulative fluoride release (137 ppm) than VB (88 ppm) (p < 0.01). Unlike VB, all experimental RMGICs showed Ca, P, and Sr release. Cell viability in the presence of extracts from experimental RMGICs (89–98%) and TC (93%) was significantly higher than for VB (4%). Experimental RMGICs showed desirable physical/mechanical properties with lower toxicity than the commercial material.